| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/11/2001 | US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/05/2001 | EP1129707A2 Methods for identifying and treating resistant tumors |
| 09/05/2001 | EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
| 09/05/2001 | CN1070491C Process for preparing 1-butyl-2-[2'-(2H-teazol-5-yl)-biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 08/30/2001 | WO2001062262A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 08/30/2001 | US20010018429 Neurotransmitter |
| 08/29/2001 | EP1127882A1 Tetrazole compounds as thyroid receptor ligands |
| 08/29/2001 | EP0968168B1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 08/29/2001 | CN1070193C Process for producing 1-butyl-2-(2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-1H-indole-3-carboxylic acid |
| 08/23/2001 | WO2001060420A1 A medicinal aerosol formulation |
| 08/23/2001 | WO2001060354A1 Cancer remedy comprising anthranilic acid derivative as active ingredient |
| 08/23/2001 | CA2400264A1 Cancer remedy comprising anthranilic acid derivative as active ingredient |
| 08/22/2001 | EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments |
| 08/22/2001 | CN1309689A Metal ligand-contg. bleaching compositions |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309123A Intermediate for preparing herbicidal 1-alkenyl tetrazolinone |
| 08/21/2001 | US6277998 Reacting 2-cyano-4-oxo-4h-benzopyran compound with hydrogen sulfide and then reacting proudct with alkyl halide; reacting the product with hydrazine or its salt and then with nitrous acid compound to obtain tetrazole compound |
| 08/21/2001 | US6277880 Chemical compounds |
| 08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | US20010014462 Coupling an enzyme-substrate reaction with a tetrazolium salt and the transfer of free electrons from the reaction to the tetrazolium salt to produce a fluorescent formazan while assaying for enzyme activity; nonradioactive detection |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/09/2001 | WO2001056979A1 Substituted cyanoacetamide derivatives and herbicides |
| 08/09/2001 | WO2000071506A3 Naphthalene ureas as glucose uptake enhancers |
| 08/09/2001 | WO2000047554A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/07/2001 | US6271375 Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes |
| 08/07/2001 | US6271237 Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors |
| 08/02/2001 | WO2001055123A1 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient |
| 08/02/2001 | DE10004328A1 New cyclic carbodiimides free of free isocyanate groups are useful as reference substances for IR spectroscopic analysis or as hydrolysis stabilizers |
| 08/01/2001 | EP1119544A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | CN1305992A Method for preparing aryl alkyl hydrogen peroxide |
| 08/01/2001 | CN1305991A Method for preparing aryl alkyl hydrogen peroxide |
| 07/31/2001 | US6268312 Oxime derivative and bactericide containing the same as active ingredient |
| 07/26/2001 | WO2001053275A2 Substituted aryl ketones |
| 07/26/2001 | WO2001052900A2 Novel orthogonally protected amino acid chelators for biomedical applications |
| 07/26/2001 | CA2397387A1 Substituted aryl ketones |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP0788487B1 Process for the preparation of tetrazoles |
| 07/25/2001 | CN1304932A Intermediate for preparing 1,4-disubstituted tetraazolequinolinone |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/24/2001 | US6264966 Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001005391A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | DE10039723A1 New heterocyclylalkoxy-substituted benzoyl ketone derivatives are herbicides useful as defoliants, desiccants and especially weedkillers |
| 07/18/2001 | EP1115701A1 Arylsulfonanilide ureas |
| 07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 07/18/2001 | EP0636025B1 Compounds useful for treating allergic or inflammatory diseases |
| 07/17/2001 | US6262275 As herbicides |
| 07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
| 07/04/2001 | EP1113011A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 07/03/2001 | US6255512 High energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, andpharmaceutical agents |
| 06/28/2001 | WO2001046202A1 Polyazacycloalkanes, organometallic complexes that incorporate them as ligands and the use of said compounds in the extraction of heavy metals |
| 06/28/2001 | WO2001046167A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 06/28/2001 | US20010005760 Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient |
| 06/27/2001 | EP1110958A1 Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
| 06/27/2001 | EP1110952A1 Carboxylic acid derivates, their preparation and use |
| 06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/21/2001 | WO2001044229A1 Chemokine receptor binding heterocyclic compounds |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/19/2001 | US6248901 Heterocyclic vinyl ethers |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/13/2001 | EP1105372A1 Methoximinophenylacetic acid amides |
| 06/13/2001 | EP0656892B1 Herbicidal 2- (4-heterocyclic-phenoxymethyl)phenoxy]-alkanoates |
| 06/13/2001 | CN1299342A Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 06/06/2001 | CN1066722C Novel acaricidally active tetrazine derivatives |
| 06/06/2001 | CN1066721C Novel tetrazolinones |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6241968 Compositions for increasing the MRI contrast in visualizing the digestive tract of patients |
| 06/05/2001 | US6241779 Metal ligand containing bleaching compositions |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | WO1999032454A9 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors |
| 05/31/2001 | WO1999024394A9 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | CN1066436C Cyclohexanes and cyclohexenes derivs. |
| 05/29/2001 | US6239284 Skin disorders; anticancer agents |
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/22/2001 | US6235785 Methods for identifying and treating resistant tumors |
| 05/22/2001 | US6235768 Osteoporosis; rheumatic disorders; antitumor agents |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001034578A1 Compounds with anti-helicobacter pylori activity |